AzTrials
AzTrials

LaryngoscopyNCT07726641

Artificial Intelligence-Assisted Training for Novice Physicians in Electronic Nasopharyngolaryngoscopy

A study testing Artificial Intelligence-Assisted Monitoring System for Electronic Nasopharyngolaryngoscopy in people with Laryngoscopy and Training, run by Ruijin Hospital at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate whether an artificial intelligence-assisted monitoring system can improve the training of novice physicians in electronic nasopharyngolaryngoscopy. The study will compare AI-assisted training with conventional training in terms of post-training examination performance. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Laryngoscopy, Training
What is being tested?
Artificial Intelligence-Assisted Monitoring System for Electronic Nasopharyngolaryngoscopy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
138 participants
Where
1 siteChina
Study dates
1 Jul 2026to 28 Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Eligibility Criteria for Novice Physicians: Inclusion Criteria

  • Aged 18 years or older.
  • Otorhinolaryngology residents or standardized residency training physicians.
  • No prior independent experience in electronic nasopharyngolaryngoscopy.
  • Holding both a physician qualification certificate and a physician practice certificate registered at the study institution.
  • Willing to participate in the study and provide written informed consent. Exclusion Criteria
  • Previous participation in other endoscopy training studies.
  • Inability to complete the required continuous training period

Eligibility Criteria for Patient Participants: Inclusion Criteria

  • Aged 18 years or older.
  • Male or female.
  • Clinical need for electronic nasopharyngolaryngoscopy.
  • Able and willing to provide written informed consent. Exclusion Criteria
  • Pregnancy.
  • History of allergy to topical anesthetics such as tetracaine or lidocaine.
  • Language or communication barriers.
  • Anatomical abnormalities, such as laryngeal stenosis, or prior nasopharyngeal or laryngeal surgery.
  • Inability to tolerate the examination position.
  • Any condition judged by the investigator to make the participant unsuitable for the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Bin Ye, MD PhD contact

+8615216616895

aydyebin@126.com

China1 site
  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

    Shanghai

    Bin Ye, MD PhD, +8615216616895, aydyebin@126.com

Other trials in China

About this study

Official title: Application of an Artificial Intelligence-Assisted Monitoring System for Electronic Nasopharyngolaryngoscopy in the Training of Novice Physicians: A Prospective, Single-Center, Randomized Controlled Study

This study aims to evaluate whether an artificial intelligence-assisted monitoring system can improve the training of novice physicians in electronic nasopharyngolaryngoscopy. The study will compare AI-assisted training with conventional training in terms of post-training examination performance.

Read the detailed description

Electronic nasopharyngolaryngoscopy is an important diagnostic procedure in otorhinolaryngology, but its examination quality is highly dependent on the operator's experience. Novice physicians may have difficulty in systematically visualizing key anatomical regions, maintaining a clear field of view, and completing a standardized examination.

Artificial intelligence-assisted monitoring systems may provide real-time feedback during endoscopic examination and help trainees improve anatomical site recognition and procedural completeness. This study is designed to evaluate the educational value of an AI-assisted monitoring system in the training of novice physicians performing electronic nasopharyngolaryngoscopy.

Novice physicians will be assigned to different training approaches, including an AI-assisted training method and a conventional training method. During the training phase, participants will receive supervised practice, with or without the support of the AI-assisted monitoring system, depending on group allocation.

Following the training period, participants will perform electronic nasopharyngolaryngoscopy under appropriate supervision. Their performance will be evaluated using recorded procedure data and expert assessment to compare outcomes between training approaches. Measures will be taken throughout the study to ensure patient safety under the guidance of experienced physicians.

Being tested
Artificial Intelligence-Assisted Monitoring System for Electronic Nasopharyngolaryngoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Artificial Intelligence-Assisted Monitoring System for Electronic NasopharyngolaryngoscopyDevice

    The AI-assisted monitoring system analyzes electronic nasopharyngolaryngoscopy video in real time and provides prompts regarding anatomical sites that have been examined. Examined anatomical sites are displayed on the screen, and the system provides information such as examination time and number of anatomical sites covered. The system is used as an adjunctive training tool and does not replace the clinical judgment of supervising physicians.

Study groups in NCT07726641
Study groupRoleWhat they receive
AI-Assisted Training GroupExperimentalNovice physicians in this group will receive additional assistance from an AI-assisted monitoring system during electronic nasopharyngolaryngoscopy training. The AI system provides real-time monitoring and visual prompts for anatomical site coverage during the examination.
Receives: Device: Artificial Intelligence-Assisted Monitoring System for Electronic Nasopharyngolaryngoscopy
Conventional Training GroupNo interventionNovice physicians in this group will receive conventional theoretical and practical training in electronic nasopharyngolaryngoscopy without real-time AI assistance during training.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post-training procedural performance score

    Each post-training procedure will be video recorded and assessed by blinded expert raters using Flexible Pharyngo-Laryngoscopy Assessment Tool (FLEXPAT). The scale includes 9 mandatory items, each scored from 1 to 5, with a total score ranging from 9 to 45 points. A higher score indicates better procedural performance.

    Measured: During each post-training assessment procedure.

Secondary outcomes (5)
  1. Anatomical Site Coverage Rate

    Measured: During each post-training assessment procedure.

  2. Examination Time

    Measured: During each post-training assessment procedure.

  3. Image Quality Score

    Image quality will be evaluated by professional raters across two dimensions based on the images captured during the procedure: preservation of anatomical sites and mucosal clarity. Each dimension is scored out of a maximum of 5 points, with a total combined score of 10 points.

    Measured: During each post-training assessment procedure.

  4. Patient Comfort

    Patient comfort will be evaluated based on clinical observation of examination-related discomfort, such as gag reflex, and categorized as good comfort, poor comfort, or very poor comfort.

    Measured: Immediately after or during each post-training assessment procedure.

  5. Trainee Satisfaction with the AI System

    Trainees in the AI-assisted training group shall complete a satisfaction questionnaire with a Likert-type scale to assess their experience using the AI-assisted monitoring system. The questionnaire consists of 10 survey items with five rating levels ranging from strongly disagree (1 point) to strongly agree (5 points).

    Measured: Within 2 weeks after completion of the training phase

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2026
  2. Study start1 Jul 2026 (estimated)
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion28 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
138 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07726641
Sponsor's protocol ID
2025-802a
Status last verified
Jun 2026
First submitted
1 Jul 2026
Last updated
24 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared publicly. The study involves clinical and endoscopic video data collected from patients, which may contain sensitive medical information. Due to privacy protection, ethical requirements, and institutional data governance policies, de-identified individual participant data will not be made available outside the research team.

Questions about this trial

What is this clinical trial studying?

A study testing Artificial Intelligence-Assisted Monitoring System for Electronic Nasopharyngolaryngoscopy in people with Laryngoscopy and Training, run by Ruijin Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bin Ye, MD PhD (+8615216616895, aydyebin@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post-training procedural performance score (time frame: During each post-training assessment procedure.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in